Tonix Pharmaceuticals Holding Corp. Annual report pursuant to Section 13 and 15(d)

Annual report pursuant to Section 13 and 15(d)

CONSOLIDATED STATEMENT OF STOCKHOLDERS' EQUITY

CONSOLIDATED STATEMENT OF STOCKHOLDERS' EQUITY (USD $) In Thousands, except Share data	Total	Preferred Stock [Member]	Common Stock [Member]	Additional Paid In Capital [Member]	Accumulated Other Comprehensive Gain (Loss) [Member]	Accumulated Deficit [Member]
Balance at Dec. 31, 2012	$ 959us-gaap_StockholdersEquity	$ 0	$ 2	$ 16,801	$ 0	$ (15,844)
Balance (in shares) at Dec. 31, 2012			2,159,159
Issuance of common stock in exchange for exercise of warrants	307	0	0	307	0	0
Issuance of common stock in exchange for exercise of warrants (in shares)			38,334
Issuance of common stock and warrants	10,042	0	3	10,039	0	0
Issuance of common stock and warrants (in shares)			2,680,000
Issuance of common stock in exchange for exercise of warrants in December 2013 ($4.25 per share)	3,761	0	1	3,760	0	0
Issuance of common stock in exchange for exercise of warrants in December 2013 ($4.25 per share) (in shares)			884,885
Issuance of common stock in exchange for exercise of warrants in December 2013 ($8.00 per share)	560	0	0	560	0	0
Issuance of common stock in exchange for exercise of warrants in December 2013 ($8.00 per share) (in shares)			70,031
Issuance of common stock in exchange for warrants exercised on a cashless basis	0	0	0	0	0	0
Issuance of common stock in exchange for warrants exercised on a cashless basis (in shares)			1,672
Stock based compensation	1,717	0	0	1,717	0	0
Warrants issued for services rendered	51	0	0	51	0	0
Foreign currency translation adjustment	(1)	0	0	0	(1)	0
Net loss	(10,884)us-gaap_NetIncomeLoss	0	0	0	0	(10,884)
Balance at Dec. 31, 2013	6,512us-gaap_StockholdersEquity	0	6	33,235	(1)	(26,728)
Balance (in shares) at Dec. 31, 2013			5,834,081
Issuance of common stock in exchange for exercise of warrants	5,661	0	1	5,660	0	0
Issuance of common stock in exchange for exercise of warrants (in shares)			1,331,911
Issuance of common stock in January 2014 ($15.00 per share) net of transaction expenses of $2,824	40,654	0	3	40,651	0	0
Issuance of common stock in January 2014 ($15.00 per share) net of transaction expenses of $2,824 (in shares)			2,898,550
Issuance of common stock and warrants	7,182	0	1	7,181	0	0
Issuance of common stock and warrants (in shares)			657,000
Issuance of common stock to acquire intellectual property rights from related party in March 2014 ($12.15 per share)	608	0	0	608	0	0
Issuance of common stock to acquire intellectual property rights from related party in March 2014 ($12.15 per share) (in shares)			50,000
Issuance of common stock in exchange for warrants exercised on a cashless basis	0	0	0	0	0	0
Issuance of common stock in exchange for warrants exercised on a cashless basis (in shares)			33,678
Stock based compensation	3,088	0	0	3,088	0	0
Foreign currency translation adjustment	3	0	0	0	3	0
Net loss	(27,616)us-gaap_NetIncomeLoss	0	0	0	0	(27,616)
Balance at Dec. 31, 2014	$ 36,092us-gaap_StockholdersEquity	$ 0	$ 11	$ 90,423	$ 2	$ (54,344)
Balance (in shares) at Dec. 31, 2014			10,805,220